1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SYNCOM FORMULATION (INDIA) LTD.

Syncom Formulation (India) Ltd. BSE: 524470

Syncom Formulation (India) Ltd. Live Share Price Today, Share Analysis and Chart

Expensive Performer
about

Syncom Formulations (India) is engaged in manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups...

Read More

21.66 -0.50 (-2.26%)

96.91% Gain from 52W Low

8.0M NSE+BSE Volume

BSE 29 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
80.0 / 100
Valuation Score
Expensive Valuation
29.7 / 100
Momentum Score
Technically Neutral
55.5 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
No estimates available

28

S

5

W

3

O

1

T

SWOT Analysis

Syncom Formulation (India) Ltd. Live Price Chart



Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf

Syncom Formulation (India) Ltd. FAQ

How is Syncom Formulation (India) Ltd. today?
Syncom Formulation (India) Ltd. today is trading in the red, and is down by -2.26% at 21.66.
Syncom Formulation (India) Ltd. is currently trading down -2.26% on an intraday basis. In the past week the stock rose 9.95%. stock has been up 34.95% in the past quarter and rose 74.26% in the past year. You can view this in the overview section.